首页> 外文期刊>Russian Open Medical Journal >Transmiocardial laser revascularization in combination with bone marrow cells implantation in the ischemic heart disease surgery: long-term results
【24h】

Transmiocardial laser revascularization in combination with bone marrow cells implantation in the ischemic heart disease surgery: long-term results

机译:缺血性心脏病手术中心内膜激光血运重建联合骨髓细胞植入术的长期结果

获取原文
           

摘要

Background ― The problem of incomplete myocardial revascularization for diffuse and distal lesions of the myocardium is still relevant. We assessed the clinical and instrumental long-term results of autologous bone marrow cell (BMC) implantation in laser channels in ischemic heart disease with diffuse and distal coronary disease.Material and Methods ― In 2007 and 2008, 35 ischemic heart disease (IHD) patients with diffuse and distal coronary disease during coronary artery bypass grafting (CABG) underwent BMC implantation in laser channels in the clinic of National Medical Research Center n.a. E.N. Meshalkin (Novosibirsk, Russia). This group was named as “BMC group”. The Control group consisted of 29 patients who underwent only CABG. Clinical and instrumental assessment of the method's effect was carried out at two weeks, six months, and six years after surgery. Long-term follow-up was performed only in 30 patients from the BMC group.Results ― After six months postoperatively, the severity of angina and heart failure based on Canadian Cardiovascular Society functional class (CCS FC) and the New York Heart Association functional class (NYHA FC) was significantly less in the BMC group than in the Control group (p=0.03 for CCS FC and p=0.04 for NYHA FC). Six years after surgery angina and heart insufficiency were at the same level. According to perfusion scintigraphy, there was a slight decrease of stable perfusion defects (SPD) in the immediate postoperative period and a more pronounced SPD reduction at six months after surgery. In BMC group, the SPD value before surgery was 18.4 (12.8, 22.4) %, 16.1 (11.6, 19.3) % at two weeks after the operation, and 13.2 (8.5, 17.3) % after six months. In the long-term period (six years), SPD was 11.9 (8.7, 14.2) % (p=0.047). A similar pattern was observed in the analysis of transient perfusion defects: baseline was 29.3 (22.1, 34.1) %, 13.1 (11.2, 16.5) % at six months, and 17.0 (14.3, 20.5) % in the long term (p=0.047). Left ventricular ejection fraction before surgery was 51 (49, 57) %, 54 (49, 57) % at two weeks after the operation, 54 (49, 58) % at six months, and 52 (49, 58) % after six years. The dynamics are not statistically significant (p=0.068).Conclusion ― Autologous BMC implantation in laser channels is an effective method of IHD surgical treatment if it is impossible to perform direct myocardial revascularization. The indirect revascularization effect is formed in the first six months after surgery and remains at the same level for six years.
机译:背景―心肌弥漫性和远端病变的心肌血运重建不完全的问题仍然存在。我们评估了自体骨髓细胞(BMC)在缺血性心脏病合并弥漫性和远端冠状动脉疾病的激光通道中植入的临床和长期效果。材料与方法― 2007年和2008年,35例缺血性心脏病(IHD)患者国家医学研究中心临床在冠状动脉旁路移植术(CABG)期间接受弥散性和远端冠状动脉疾病的激光通道BMC植入E.N. Meshalkin(俄罗斯新西伯利亚)。该组被称为“ BMC组”。对照组包括仅接受CABG的29例患者。在手术后两周,六个月和六年进行了该方法效果的临床和仪器评估。结果:BMC组仅对30例患者进行了长期随访。结果―术后六个月,根据加拿大心血管协会功能分类(CCS FC)和纽约心脏协会功能分类,心绞痛和心力衰竭的严重程度BMC组的(NYHA FC)明显少于对照组(CCS FC的p = 0.03,NYHA FC的p = 0.04)。手术后六年,心绞痛和心脏功能不全处于同一水平。根据灌注闪烁显像术,稳定的灌注缺陷(SPD)在术后即刻略有减少,而在术后六个月时SPD的减少更为明显。在BMC组中,手术前的SPD值在手术后两周为18.4(12.8,22.4)%,在手术后两周为16.1(11.6,19.3)%,六个月后为13.2(8.5,17.3)%。在长期(六年)中,SPD为11.9(8.7,14.2)%(p = 0.047)。在短暂性灌注缺陷分析中观察到了类似的模式:基线为六个月的29.3(22.1,34.1)%,六个月为13.1(11.2,16.5)%,长期为17.0(14.3,20.5)%(p = 0.047) )。术前左心室射血分数为51(49,57)%​​,术后两周为54(49,58)%,六个月为54(49,58)%,六个月为52(49,58)%年份。动态无统计学意义(p = 0.068)。结论―如果不可能直接进行心肌血运重建,则在激光通道中自体BMC植入是IHD外科治疗的有效方法。间接血运重建效应在手术后的前六个月形成,并在六年内保持相同水平。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号